Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2

Biochemistry

Volumn 47, Issue 7, 2008, Pages 1928-1937

  Chen, Kang ^a   Bachtiar, Indra ^a   Piszczek, Grzegorz ^a   Bouamr, Fadila ^b   Carter, Carol ^c   Tjandra, Nico ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR DYNAMICS; MOLECULAR INTERACTIONS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; VIRUSES;

ANEMIA VIRUS MATRIX PROTEIN; RETROVIRUSES;

PROTEINS;

MATRIX PROTEIN; MONOMER; OLIGOMER; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ARTICLE; BINDING KINETICS; BINDING SITE; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; ENTROPY; EQUILIBRIUM CONSTANT; EQUINE INFECTIOUS ANEMIA VIRUS; LIPID ANALYSIS; MOLECULAR DYNAMICS; MYRISTYLATION; NITROGEN NUCLEAR MAGNETIC RESONANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRACENTRIFUGATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BIOPOLYMERS; INFECTIOUS ANEMIA VIRUS, EQUINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PROTEIN CONFORMATION; VIRAL MATRIX PROTEINS;

EQUINE INFECTIOUS ANEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 39649098475     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi701984h     Document Type: Article

References (41)

1. Scarlata, S., and Carter, C. (2003) Role of HIV-1 Gag domains in viral assembly, Biochim. Biophys. Acta. 1614, 62-72.
2. Morita, E., and Sundquist, W. I. (2004) Retrovirus budding, Annu. Rev. Cell Dev. Biol. 20, 395-425.
3. Chapman, M. S., and Liljas, L. (2003) Structural folds of viral proteins, Adv. Protein Chem. 64, 125-196.
4. Bryant, M., and Ratner, L. (1990) Myristoylation-dependent replication and assembly of human immunodeficiency virus 1, Proc. Natl. Acad. Sci. U.S.A. 87, 523-527.
5. Bouamr, F., Scarlata, S., and Carter, C. (2003) Role of myristylation in HIV-1 Gag assembly, Biochemistry 42, 6408-6417.
6. Zhou, W., Parent, L. J., Wills, J. W., and Resh, M. D. (1994) Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids, J. Virol. 68, 2556-2569.
7. Hill, C. P., Worthylake, D., Bancroft, D. P., Christensen, A. M., and Sundquist, W. I. (1996) Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: Implications for membrane association and assembly, Proc. Natl. Acad. Sci. U.S.A. 93, 3099-3104.
8. Massiah, M. A., Starich, M. R., Paschall, C., Summers, M. F., Christensen, A. M., and Sundquist, W. I. (1994) Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein, J. Mol. Biol. 244, 198-223.
9. Matthews, S., Barlow, P., Clark, N., Kingsman, S., Kingsman, A., and Campbell, I. (1995) Refined solution structure of p17, the HIV matrix protein, Biochem. Soc. Trans. 23, 725-729.
10. McLaughlin, S., and Murray, D. (2005) Plasma membrane phosphoinositide organization by protein electrostatics, Nature 438, 605-611.
11. Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K., and Freed, E. O. (2004) Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane, Proc. Natl. Acad. Sci. U.S.A. 101, 14889-14894.
12. Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., and Summers, M. F. (2006) Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly, Proc. Natl. Acad. Sci. U.S.A. 103, 11364-11369.
13. Saad, J. S., Loeliger, E., Luncsford, P., Liriano, M., Tai, J., Kim, A., Miller, J., Joshi, A., Freed, E. O., and Summers, M. F. (2007) Point mutations in the HIV-1 matrix protein turn off the myristyl switch, J. Mol. Biol. 366, 574-585.
14. Hatanaka, H., Iourin, O., Rao, Z. H., Fry, E., Kingsman, A., and Stuart, D. I. (2002) Structure of equine infectious anemia virus matrix protein, J. Virol. 76, 1876-1883.
15. Provitera, P., Bouamr, F., Murray, D., Carter, C., and Scarlata, S. (2000) Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions, J. Mol. Biol. 296, 887-898.
16. Koradi, R., Billeter, M., and Wuthrich, K. (1996) MOLMOL: A program for display and analysis of macromolecular structures, J. Mol. Graphics 14, 51-55.
17. Schuck, P. (2003) On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation, Anal. Biochem. 320, 104-124.
18. Bax, A., and Grzesiek, S. (1993) Methodological Advances in Protein NMR, Acc. Chem. Res. 26, 131-138.
19. Ottiger, M., Delaglio, F., and Bax, A. (1998) Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra, J. Magn. Reson. 131, 373-378.
20. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes, J. Biomol. NMR 6, 277-293.
21. Garrett, D. S., Seok, Y. J., Peterkofsky, A., Clore, G. M., and Gronenborn, A. M. (1997) Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system, Biochemistry 36, 4393-4398.
22. Maciejewski, M. W., Shin, R., Pan, B., Marintchev, A., Denninger, A., Mullen, M. A., Chen, K., Gryk, M. R., and Mullen, G. P. (2001) Solution structure of a viral DNA repair polymerase, Nat. Struct. Biol. 8, 936-941.
23. 15N relaxation using inverse detected two-dimensional NMR spectroscopy: The central helix is flexible, Biochemistry 31, 5269-5278.
24. Peng, J. W., Thanabal, V., and Wagner, G. (1991) Improved Accuracy of Heteronuclear Transverse Relaxation-Time Measurements in Macromolecules: Elimination of Antiphase Contributions, J. Magn. Reson. 95, 421-427.
25. Loria, J. P., Rance, M., and Palmer, A. G. (1999) A relaxation- compensated Carr-Purcell-Meiboom-Gill sequence for characterizing chemical exchange by NMR spectroscopy, J. Am. Chem. Soc. 121, 2331-2332.
26. Ishima, R., and Torchia, D. A. (1999) Estimating the time scale of chemical exchange of proteins from measurements of transverse relaxation rates in solution, J. Biomol. NMR 14, 369-372.
27. Zweckstetter, M., and Bax, A. (2000) Prediction of sterically induced alignment in a dilute liquid crystalline phase: Aid to protein structure determination by NMR, J. Am. Chem. Soc. 122, 3791-3792.
28. Cornilescu, G., Marquardt, J. L., Ottiger, M., and Bax, A. (1998) Validation of protein structure from anisotropic carbonyl chemical shifts in a dilute liquid crystalline phase, J. Am. Chem. Soc. 120, 6836-6837.
29. Bax, A. (2003) Weak alignment offers new NMR opportunities to study protein structure and dynamics, Protein Sci. 12, 1-16.
30. Kern, D., and Zuiderweg, E. R. (2003) The role of dynamics in allosteric regulation, Curr. Opin. Struct. Biol. 13, 748-757.
31. Palmer, A. G., III, Kroenke, C. D., and Loria, J. P. (2001) Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules, Methods Enzymol. 339, 204-238.
32. Palmer, A. G., III (2004) NMR characterization of the dynamics of biomacromolecules, Chem. Rev. 104, 3623-3640.
33. Murray, P. S., Li, Z. H., Wang, J. Y., Tang, C. L., Honig, B., and Murray, D. (2005) Retroviral matrix domains share electrostatic homology: Models for membrane binding function throughout the viral life cycle, Structure 13, 1521-1531.
34. Alfadhli, A., Huseby, D., Kapit, E., Colman, D., and Barklis, E. (2007) Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer, J. Virol. 81, 1472-1478.
35. Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D., and Summers, M. F. (2004) Entropic switch regulates myristate exposure in the HIV-1 matrix protein, Proc. Natl. Acad. Sci. U.S.A. 101, 517-522.
36. Scheifele, L. Z., Rhoads, J. D., and Parent, L. J. (2003) Specificity of plasma membrane targeting by the Rous sarcoma virus Gag protein, J. Virol. 77, 470-480.
37. Dalton, A. K., Murray, P. S., Murray, D., and Vogt, V. M. (2005) Biochemical characterization of Rous sarcoma virus MA protein interaction with membranes, J. Virol. 79, 6227-6238.
38. Campbell, S., Fisher, R. J., Towler, E. M., Fox, S., Issaq, H. J., Wolfe, T., Phillips, L. R., and Rein, A. (2001) Modulation of HIV-like particle assembly in vitro by inositol phosphates, Proc. Natl. Acad. Sci. U.S.A. 98, 10875-10879.
39. Shkriabai, N., Datta, S. A., Zhao, Z., Hess, S., Rein, A., and Kvaratskhelia, M. (2006) Interactions of HIV-1 Gag with assembly cofactors, Biochemistry 45, 4077-4083.
40. Datta, S. A., Zhao, Z., Clark, P. K., Tarasov, S., Alexandratos, J. N., Campbell, S. J., Kvaratskhelia, M., Lebowitz, J., and Rein, A. (2007) Interactions between HIV-1 Gag molecules in solution: An inositol phosphate-mediated switch, J. Mol. Biol. 365, 799-811.
41. Kiessling, L. L., Gestwicki, J. E., and Strong, L. E. (2000) Synthetic multivalent ligands in the exploration of cell-surface interactions, Curr. Opin. Chem. Biol. 4, 696-703.